medigital

"With diverse digital solutions, we want to enable therapists to individualize and improve patient management with non-pharmacological intervention options on the one hand, while increasing patient sovereignty on the other."

Dr. Felix Lambrecht

Vision

We are shaping healthcare provision through digitalisation – for a healthier world. Medigital knows what healthcare provision means in a digital age, and supports the MEDICE Health Family in establishing solutions that sustainably strengthen healthcare.

Mission

Supporting patients holistically, opening up new treat- ment options and creating efficiency in the healthcare system: through digital therapeutics and diagnostic solutions, more patients will receive better care faster in the future, doctors and therapists will pursue their profession with greater enjoyment and people will be able to better manage their health.

To achieve this, we are linking know-how from the me- dicinal product sector with new technologies to create health solutions based on psychology, algorithms and information technology.

Focus

“Creating new offers together” – we want to serve the established markets of the MEDICE Health Family with a joint portfolio of offers. To do this, we are building a portfolio of complementary pharmacological and non-pharmacological interventions that open up new treatment paths for prescribers. We will also make these non-pharmacological offers available to patients and those affected themselves via direct-to-consumer channels to provide even broader access to state-of-the-art care. The direct contact with patients also generates highly valuable health data, which can be used in an anonymised form to develop new offers.

In the field of gynaecology, the acquisition of femfeel led to the first portfolio of its kind with the Schaper & Brümmer product Remifemin®. For families affected by ADHD, we have started a dual launch in Germany with Mellozzan and the parent app hiPanya in order to bring further offers for children and adolescents with ADHD and depression (in cooperation with Selfapy) onto the market. Within nephrology, we want to alleviate the psychological strain on patients and help them to live better with their indication – in a physically and psychosocially stable manner.

In all areas, we are also experimenting with new technologies such as wearables, virtual reality (VR) and artificial intelligence in order to make the embedding of interventions into the patient’s everyday life even simpler and more fun. One example here is the cooperation with the start-up Brainjo, which has worked with us to develop virtual game realities for the treatment of ADHD.